Researchers discovered that nearly 70 per cent of suspected frontotemporal dementia patients ultimately did not have the disease in a study aimed at identifying factors

A complementary drug to combat Alzheimer’s disease could target a specific part of the nerve cell protein tau. This is the finding of new research

Years before tau tangles show up in brain scans of patients with Alzheimer’s disease, a biomarker test can detect small amounts of the clumping-prone tau

A research team has discovered that the two key pathological hallmarks of Alzheimer’s — tau protein and beta-amyloid — affect brain circuits in distinct yet